Linezlid en es it fr

Linezlid Brand names, Linezlid Analogs

Linezlid Brand Names Mixture

  • Gastrografin - Liq Orl (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Gastrografin Liq (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Hypaque-M 76% (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Hypaque-M 76% Liq (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Hypaque-M Liq 76% Usp (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Md-60 (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Md-76 (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Renocal-76 (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Renografin-60 - Liq Iv (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Renografin-60 Liq (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Renografin-76 - Liq Iv (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Renografin-76 Liq (Diatrizoate Meglumine + Diatrizoate Sodium)
  • Sinografin (Diatrizoate Meglumine + Meglumine Iodipamide)
  • Sinografin - Liq Iu (Diatrizoate Meglumine + Meglumine Iodipamide)

Linezlid Chemical_Formula

MgSO4

Linezlid RX_link

http://www.rxlist.com/cgi/generic3/mgso4.htm

Linezlid fda sheet

Linezlid msds (material safety sheet)

Linezlid MSDS

Linezlid Synthesis Reference

No information avaliable

Linezlid Molecular Weight

120.369 g/mol

Linezlid Melting Point

1124 oC (decomposition)

Linezlid H2O Solubility

710 mg/mL

Linezlid State

Solid

Linezlid LogP

-0.91

Linezlid Dosage Forms

Capsule; Drops; Liquid; Powder; Powder for solution; Solution; Tablet

Linezlid Indication

Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.

Linezlid Pharmacology

Magnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.

Linezlid Absorption

No information avaliable

Linezlid side effects and Toxicity

LD50 = 1200 mg/kg (rat, subcutaneous). May be harmful if swallowed. May act as an irritant. Adverse reactions include hypotension, ECG changes, diarrhea, urinary retention, CNS depression and respiratory depression.

Linezlid Patient Information

Linezlid Organisms Affected

Humans and other mammals